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gene common to HT and NT rats: Atp2a2. Eight Coord+ genes speci¿ c to HT 
rats were part of EnMet (Hadh, Hadha, Acadvl, Pfkm, Pkm2, Dlst, Sdhd, and 
Ndufa9) and 12 were external to the studied functions. The changes between 
HF and NF humans were dramatic: no Coord+ or Coord- was found in HF for 
CC and ECM, in line with their extreme cardiac dysfunction.
At the mRNA level, the major cardiac cellular functions of functional hearts 
are involved in a large coordination network involving positive and negative 
links. Large changes were found according to the functional state of the heart, 
allowing new physiopathological views in such complex diseases and pointing 
out new potential biomarkers of some aspects of cardiac remodeling. 
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Background: Patients with abdominal aortic aneurysms (AAAs) have 
greater incidence of incisional hernia (IH) after midline laparotomy compared 
to those with aortic occlusive disease (AOD). IH may occur due to defective 
healing response inherent to AAA pathobiology. To test this hypothesis, we 
investigated functional and genetic alterations of abdominal wall associated 
to AAA.
Methods: Fascial ¿ broblasts (FF) were isolated by the outgrowth of cells 
from abdominal wall linea alba explants from patients undergoing surgery for 
AAA or AOD. Cells were assessed for their wound healing functional abili-
ties, (ie proliferation, migration, apoptosis and contraction) and gene expres-
sion pattern (microarrays analysis).
Results: We found no difference in cell proliferation between patients 
with AAA and those with AOD. Wound repair in response to scratch injury 
to conÀ uent cell monolayer was impaired in AAA, as reÀ ected by the rate 
of wound coverage by cells (-35% AAA vs. AOD, p<0.001). Nucleosomes 
release by FF showed a reduced apoptosis induction in AAA than in AOD 
(-39%, p<0.05). The ability of FF to contract collagen matrix was more pro-
nounced in AOD than in AAA patients (+32%, p<0.05). Microarray analysis 
revealed a total of 47 genes differentially expressed out of 28000 between 
the two groups (34 up-regulated, log2 ratio>0.5 and 13 down-regulated, log2 
ratio<-0.5). Some of these genes are related to cell migration/adhesion, cytos-
keleton assembly and apoptosis, corroborating the functional differences 
observed between AAA and AOD cells. In addition, several inÀ ammatory 
genes were up-regulated in AAA cells suggesting that dysfunctional inÀ am-
mation is also of the importance in the alteration of wound healing in AAA 
patients.
Conclusion: Our data suggest that atherosclerotic AAAs develop in associa-
tion to an altered response to injury, extended beyond the aorta. Differentially 
expressed genes may represent novel targets for treatment of AAA.
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Smoking is a major cardiovascular risk factor. It is well established that 
monoamine oxidase (MAO) activity is decreased in smokers. We postulated 
that serotonin (5-HT), a major substrate for MAO secreted from activated pla-
telets, could be involved in smoking-induced vascular modi¿ cations.
We studied 115 men (age: 35-56 years) with no history of cardiovascular 
disease and no diabetes, including 44 smokers, 37 former smokers (mean 
duration of abstinence: 13 years), and 34 who had never smoked. We found 
that smoking durably modi¿ es the platelet 5-HT/MAO system by reducing 
the methylation of the MAO gene promoter resulting in an increase in MAO 
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17E-Estradiol (E2) exerts pleiotropic effects and in particular plays key 
roles on reproduction and on cardiovascular protection. Effects of E2 can be 
mediated through two estrogen receptors (ER) D and E but ERD was shown 
to be the major actor for most of the actions of E2. As for the other member 
of the nuclear receptor family, ER stimulates target gene transcription through 
two activation functions (AFs), AF-1 and AF-2 to modulate transcriptional 
response. Our group demonstrated that although AF-1 is necessary for uterine 
action of E2, AF-1 of ERD is dispensable to mediate atheroprotective effect of 
E2. We show now that AF-2 is also absolutely required for the E2 action on 
uterine hypertrophy and on fatty streak prevention. We also search to deter-
mine two set of early genes regulated by ERD AF-1 and 2 in the aorta and in 
the uterus. To this aim, ovariectomized wild type mice or deleted for respec-
tively AF-1 or AF-2 of ERD were treated for 6 hours with E2 or by various 
selective estrogen receptor modulators (SERMs) such as ERD or ERE speci¿ c 
agonists, tamoxifen (AF-1 agonist/AF-2 antagonist) and enterolactone (AF-2 
preferential agonist). A new approach of high throughput real-time PCR ins-
trument was used to analyze target genes expression in aorta and uterus.
Identi¿ cation of such set of target genes will be presented at the meeting 
and should be helpful to decipher the respectives roles of AF-1 and AF-2 in 
these two target organs. This approach should help to screen SERMs able to 
elicit the E2 bene¿ cial vascular effects but not on the uterus.
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Although essential for a proper functioning of the cardiac tissue, the coor-
dination of cellular functions has been little explored at the mRNA level. Our 
aim was to investigate this coordination within and between functions and to 
identify key coordinating genes.
We examined energy metabolism (EnMet), cardiac contraction (CC), and 
extracellular matrix (ECM) using microarray data from left ventricles obtained 
in normotensive (NT) and hypertensive (HT) rats, and in non-failing (NF) and 
heart failing (HF) humans. Analyzing separately positive and negative corre-
lations between transcripts, we computed signed clustering rate of each func-
tion, and signed connectivity of the microarray genes with each function. 
Connectivity higher than random (p<0.05) de¿ ned genes positively (Coord+) 
or negatively (Coord-) coordinated with one function.
In most cases, each function had high positive clustering rate and many 
external Coord+ and Coord-. There were 1.5 to 3 times more Coord- and 
Coord+ in HT than in NT rats, with 60% common to both groups. In each 
group, Coord+ and Coord- common to EnMet and CC pointed out the cou-
pling of these functions and were more numerous in HT than in NT rats (26 
vs 7 Coord+ and 10 vs 5 Coord-). This coupling involved only one Coord+ 
▼ ▼
01_corpus_ok.indd   69 26/04/2011   15:50:14
70 Archives of Cardiovascular Diseases Supplements (2011) 2, 1-91
© Elsevier Masson SAS. All rights reserved.
new miR-1 and two miR-133 targets by this approach and at the endogenous 
RNA and protein level. The next step in our study will be to investigate on 
the role of these new targets of miR-1 and miR-133 targets in the pathological 
remodeling of cardiomyocytes.
0355
Cardiac transcriptome analysis of a mouse model of dilated cardiomy-
opathy related to Lmna gene mutation
Marie-Elodie Cattin [Orateur] (1), Wassila Carpentier (2), Nicolas 
Cagnard (3), Gisèle Bonne (1), Nicolas Vignier (1)
(1) UM76 UPMC Paris 6, U974 Inserm, UMR7215 CNRS, Institut de 
Myologie, GH Pitié-Sal, Paris, France – (2) 2Plate-forme Post-Génomique 
P3S, INSERM, UPMC Paris 6, GH Pitié-Salpêtrière, Par, Paris, France – 
(3) 3Plateforme Bio-informatique, Descartes, Faculté de Necker, Paris, 
Paris, France
Lamin A and C, encoded by LMNA gene, localize at the inner face of the 
nuclear membrane and interact with many proteins and DNA. Mutations 
reported all along the LMNA gene are responsible for multiple diseases inclu-
ding Emery-Dreifuss muscular dystrophy (EDMD). Among them, the deletion 
of the lysine 32 (K32) leads to a severe EDMD pheontype with the ¿ rst cli-
nical signs appearing before the age of 2 and a loss of ambulation before the 
age of 10. The heterozygous mice carrying the K32 mutation (LmnaK32/+) 
develop a dilated cardiomyopathy (DCM) at about 30 weeks without muscle 
involvement.
To de¿ ne the earliest pathophysiological pathways involved in the develop-
ment of the DCM, we perform transcriptome analysis using Illumina’s mouse 
whole-genome expression arrays on heart from LmnaK32/+ mice before the 
development of any clinical signs. The RNA samples were extracted from 10 
LmnaK32/+ and 8 wild type mice aged of 10 weeks. Statistical analysis resulted 
from the following workÀ ow: quantile normalization without background sub-
traction, non-supervised clustering analysis and multiple comparisons test. To 
validate the results we performed RT-qPCR on 6 genes in relation to their 
change fold and their probability score.
We found 30 up and 5 down-regulated genes. Their fold change ranged 
between -0,5 to +2,5. This result is in concordance with our hypothesis expec-
ting only few genes dysregulated due to the observation window located 18 
weeks before the ¿ rst clinical sign. Among these genes, about 40% were also 
up or down regulated in cardiomyopathies or in activation or inhibition of 
signaling pathways controlling cardiac function.
In conclusion, only few genes were both dysregulated in LmnaK32/+ mice 
and implicated in other cardiomyopathies suggesting these genes are pro-
bably involved in early pathophysiological pathways. Investigation of these 
pathways may produce new insights in mechanisms leading to cardiomyopa-
thies and may identify new therapeutic targets.
protein synthesis persisting more than ten years after quitting smoking. Like 
platelet 5-HT, the plasma level of norepinephrine (NE), another MAO substrate 
involved in affective disorders, signi¿ cantly correlated with the MAO protein 
amount, and with the length of smoking. Finally, the smoking-induced increase 
in the amount of MAO-B protein depended on its initial level in platelets.
In conclusions, MAO could be a readily accessible and helpful marker to 
be studied in the risk evaluation of smoking-related diseases, from cardiovas-
cular and pulmonary diseases to depression, anxiety and cancer. In addition, 
the smoking-induced MAO demethylation can be considered as a hallmark of 
smoking-related diseases, similarly to other aberrant DNA methylations. This 
¿ nding illustrates the importance of lifestyle inÀ uence on epigenetic patterns 
in various tissues. 
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Serum response factor (SRF) is a transcription factor of the MADS box 
family that regulates structural and metabolic genes in many tissues. Using a 
mouse Cre-Lox model, we have shown previously that SRF inactivation in the 
adult heart results in dilated cardiomyopathy (DCM) leading to heart failure. 
Recent studies revealed SRF as a regulator of miRNAs (miRs), which are 
endogenous small RNAs that can inhibit the expression of protein coding mes-
senger RNAs. Our project aims to analyze the role of SRF in the regulation of 
miRs in the adult heart. We extracted total RNA from hearts of controls and 
SRF-KO mice at different stages of DCM and in hypertrophic settings, i.e. 
phenylephrin infusion with mini-osmotic pumps (PE, 80 mg/kg/day, 15 days). 
Among 333 miRs that we found to be expressed in the mouse heart, we iden-
ti¿ ed 2 clusters of differentially regulated miRs: a large cluster up-regulated 
by PE in an SRF-independent manner and a small cluster of miRs speci¿ cally 
down-regulated in the heart of the SRF-KO, which includes miR-1 and miR-
133. To identify miR targets, we adopted a non-biased discovery approach by 
combining the results of our miRNA screen with a 2D DIGE proteomic screen 
performed in the SRF-KO heart. This approach is based on the hypothesis that 
there should be an inverse correlation between the list of differentially regu-
lated proteins and the list of differentially regulated miRs. We focused our ¿ rst 
analysis on up-regulated proteins encoded by mRNAs that could be the targets 
of the cluster of down-regulated miRs. We tested miRNA: mRNA interaction 
by cotransfection of H9c2 rat cardiac cells with miRs precursors and lucife-
rase miR-reporter constructs containing the mRNA 3’UTR. We validated three 
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